Aerocrine AB

Aerocrine AB (publ), together with its subsidiaries, operates as a medical technology company primarily in Europe, the United States, North America, Asia, and the Oceania. The company offers NIOX MINO and NIOX VERO devices for checking inflammatory conditions in airways, as well as enhancing diagnosis, treatment, and follow-up of people with asthma. It serves research and pharmaceutical development companies, specialist doctors, outpatient and primary care clinics, and patients. The company was founded in 1997 and is headquartered in Solna, Sweden. As of June 26, 2015, Aerocrine AB operates as a subsidiary of Circassia Limited.